Robert G. Shawah's Net Worth

-$6 Thousand

Estimate Recalculated Nov 1, 2024 03:34AM EST

Who is Robert G. Shawah?

Robert G. Shawah does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dipexium Pharmaceuticals, Inc., AMERI Holdings, Inc., and Acurx Pharmaceuticals, Inc..

SEC CIK

Robert G. Shawah's CIK is 0001601121

Past Insider Trading and Trends

2014 was Robert G. Shawah's most active year for acquiring shares with 2 total transactions. Robert G. Shawah's most active month to acquire stocks was the month of December. 2016 saw Robert G. Shawah paying a total of $660,400.00 for 65,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dipexium Pharmaceuticals, Inc. No price found

Chief Accounting Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 17
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 5
Form 4
∞
500
$12.00
$6,000.00
500
Mar 18
Form 3
—
0
—
—
0
No matching records found

AMERI Holdings, Inc. (ENVB) Snapshot price: $0.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 20
Form 3
—
0
—
—
0
No matching records found

Acurx Pharmaceuticals, Inc. (ACXP) Snapshot price: $2.1

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Jun 29 - Jul 1
Form 3
—
0
—
—
0
No matching records found